Dashboard
Manage Tickers

SAVACASSAVA SCIENCES INC

Nasdaq cassavasciences.com


$ 29.00 $ 0.10 (0.35 %)    

Friday, 30-Aug-2024 12:54:01 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.66 $ -2.71 (-0.57 %)
DIA $ 412.83 $ -2.01 (-0.48 %)
SPY $ 559.04 $ -1.73 (-0.31 %)
TLT $ 96.85 $ -0.82 (-0.84 %)
GLD $ 230.79 $ -1.60 (-0.69 %)
$ 28.51
$ 28.90
$ 28.51 x 100
$ 150.00 x 126
$ 28.33 - $ 29.53
$ 8.79 - $ 42.20
1,407,442
na
1.37B
$ 1.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-01-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 03-23-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-12-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 03-26-2020 12-31-2019 10-K
20 10-29-2019 09-30-2019 10-Q
21 08-12-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 07-26-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 02-06-2018 12-31-2017 10-K
28 11-01-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 04-26-2017 03-31-2017 10-Q
31 03-07-2017 12-31-2016 10-K
32 10-26-2016 09-30-2016 10-Q
33 07-19-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-03-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 07-23-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-18-2015 12-31-2014 10-K
40 11-05-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cassava-sciences-granted-us-patent-us-12065440-b2-application-17850198-for-solid-polymorphs-of-a-flna-binding-compound-and-its-hydrochloride-salts-filed-on-6272022
Cassava Sciences Granted U.S. Patent US 12...
08/20/2024 19:09:05

9-health-care-stocks-whale-activity-in-todays-session
9 Health Care Stocks Whale Activity In Tod...
08/13/2024 17:35:23

hc-wainwright--co-reiterates-neutral-on-cassava-sciences
HC Wainwright & Co. Reiterates Neutral on ...
08/13/2024 11:21:41

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) with a Neutral.

rodman--renshaw-reiterates-buy-on-cassava-sciences-maintains-107-price-target
Rodman & Renshaw Reiterates Buy on Cassava...
08/08/2024 18:29:15

Rodman & Renshaw analyst Elemer Piros reiterates Cassava Sciences (NASDAQ:SAVA) with a Buy and maintains $107 price target.

watching-cassava-sciences-shares-see-volume-to-the-upside-as-traders-circulate-unconfirmed-analyst-comments-suggesting-confirmed-guidance-for-completion-of-its-first-pivotal-alzheimers-trial-by-year-end-2024-anticipating-a-potential-settlement-of-an-sec-investigation-reiterating-their-buy-rating-and-107-pt
Watching Cassava Sciences; Shares See Volu...
08/08/2024 18:04:15

cassava-sciencess-net-cash-use-in-operations-for-second-half-2024-is-expected-to-be-80m-90m-which-includes-an-estimated-40m-loss-contingency-related-to-advanced-discussions-to-resolve-the-secs-investigation-the-company-estimates-cash-at-year-end-2024-of-117m-127m
Cassava Sciences's Net Cash Use In Operati...
08/08/2024 12:05:28

cassava-sciences-q2-2024-gaap-eps-013-may-not-be-comparable-to-040-estimate
Cassava Sciences Q2 2024 GAAP EPS $0.13 Ma...
08/08/2024 12:03:51

heres-how-much-100-invested-in-cassava-sciences-5-years-ago-would-be-worth-today
Here's How Much $100 Invested In Cassava S...
08/07/2024 20:00:50

market-whales-and-their-recent-bets-on-sava-options
Market Whales and Their Recent Bets on SAV...
08/06/2024 17:45:47

whats-going-on-with-cassava-sciences-today
What's Going On With Cassava Sciences Today?
08/05/2024 19:44:51

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday. Here's what you need to know.

cassava-sciences-shares-are-trading-higher-today-what-you-need-to-know
Cassava Sciences Shares Are Trading Higher...
08/02/2024 19:51:45

Cassava Sciences, Inc. (NASDAQ: SAVA) saw its stock price soar by 15.5% to $27.13, an increase of $3.64, amid rising short inte...

sava---analyzing-cassava-sciencess-short-interest
(SAVA) - Analyzing Cassava Sciences's Shor...
08/02/2024 16:15:13

8-best-performing-small-caps-in-july-find-out-which-stock-jumped-803
8 Best-Performing Small Caps In July: Find...
08/01/2024 20:54:40

Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 ...

match-group-posts-upbeat-sales-joins-modine-manufacturing-scotts-miracle-gro-nvidia--and-other-big-stocks-moving-higher-on-wednesday
Match Group Posts Upbeat Sales, Joins Modi...
07/31/2024 17:05:44

cassava-sciences-announces-expansion-of-open-label-extension-trials-by-up-to-an-additional-36-months-to-provide-participants-the-opportunity-to-continue-on-treatment-if-they-desire-pending-results-of-the-ongoing-phase-3-trials
Cassava Sciences Announces Expansion Of Op...
07/30/2024 12:19:19

Ongoing open-label extension trials of simufilam in Alzheimer's disease to be extended by up to an additional 36 months.The...

heres-how-much-1000-invested-in-cassava-sciences-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Cassava ...
07/23/2024 16:30:52

cassava-sciences-advances-alzheimers-drug-through-high-stakes-phase-3-trials
Cassava Sciences Advances Alzheimer's Drug...
07/22/2024 18:03:12

Cassava Sciences' Phase 3 trials for Alzheimer's drug simufilam could change treatment standards. With trials costing m...

why-crowdstrike-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-mondays-mid-day-session
Why CrowdStrike Shares Are Trading Lower B...
07/22/2024 17:28:23

iqvia-posts-upbeat-earnings-joins-terex-reddit-and-other-big-stocks-moving-higher-on-monday
IQVIA Posts Upbeat Earnings, Joins Terex, ...
07/22/2024 15:28:59

cassava-sciences-executive-chairman-rick-barry-issues-an-open-letter-to-shareholders-employees-principal-investigators-patients-and-their-loved-ones-on-july-21-2024
Cassava Sciences Executive Chairman Rick B...
07/22/2024 12:18:31

https://www.sec.gov/Archives/edgar/data/1069530/000143774924023128/ex_701112.htm 

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION